恩华药业 (002262.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(恩华药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,357,565,651.125,041,504,467.273,655,985,179.262,400,328,791.851,178,806,488.434,298,513,062.143,120,125,711.282,001,098,966.90992,593,188.54
 营业利润(元) 304,871,280.841,182,344,167.981,005,456,875.82626,092,044.42261,579,559.011,003,465,495.42848,886,121.09514,626,738.93209,692,665.09
 利润总额(元) 299,736,147.101,168,644,097.611,000,774,839.69621,989,781.31258,499,710.15989,906,886.70844,158,011.10511,347,151.19208,222,789.84
 净利润(元) 264,638,776.411,034,247,287.51883,414,665.34544,408,392.98225,173,396.19880,388,553.10735,852,387.38443,324,859.15186,740,460.44
 归属于母公司股东的净利润(元) 265,282,248.031,036,918,058.61885,641,307.43544,703,014.00227,429,413.46900,926,029.55741,874,815.09447,503,891.51188,688,696.04
盈利能力:
 销售毛利率(%) 70.7872.8373.1173.7573.3376.2676.4375.8475.34
 销售净利率(%) 19.4920.5124.1622.6819.1020.4823.5822.1518.81
 净资产收益率(%) 4.2317.2015.059.794.15----
 总资产报酬率ROA(%) 4.0716.6514.819.673.98----
 投入资本回报率ROIC(%) 3.9616.9014.659.293.9116.8214.078.723.70
营运能力:
 存货周转率(次) 0.612.041.430.920.46----
 应收账款周转率(次) 1.425.434.162.881.57----
 总资产周转率(次) 0.190.730.550.380.18----
偿债能力:
 资产负债率(%) 12.2212.5312.2213.2214.7513.8412.9313.4715.81
 股东权益比率(%) 88.1087.8088.3387.3385.8386.7487.4486.8984.50
 已获利息倍数(倍) -46.16-59.67-99.81-154.65-101.52-46.63-145.63-119.95-123.50
 流动比率 6.656.466.526.035.455.866.406.135.21
 速动比率 5.785.595.535.044.554.855.345.104.40
发展能力:
 营业收入增长率(%) 15.1617.2817.1719.9518.769.227.897.309.79
 营业利润增长率(%) 16.5517.8318.4421.6624.748.388.746.178.57
 税后利润增长率(%) 16.6415.1219.3821.7220.5312.9310.258.9112.45
 净资产增长率(%) 14.5314.4615.4815.4614.4914.2614.3716.4819.04
 总资产增长率(%) 11.5713.0714.3114.8712.7213.7714.8716.8720.57

前瞻产业研究院